Private Label Polyglutamic Acid Moisturizer Manufacturer Low MOQ

Most private label cosmetic manufacturers who work with polyglutamic acid moisturizers accept minimum order quantities between 200 and 1,000 units for their lowest tier. The exact floor depends on several variables, and understanding them lets you negotiate more effectively. Formula complexity is the first lever. A manufacturer who already has a PGA moisturizer base on file — one that has cleared stability and safety testing — will accept lower MOQs (sometimes as few as 200 units) because their development risk is minimal. If you need a fully custom formula, many facilities set their pilot-batch floor at 500–1,000 units to cover the chemist hours, raw-material sampling, and equipment changeover costs. Packaging type matters almost as much as formula. Standard airless pumps and disc-top jars are stocked by most component suppliers at low quantities, so manufacturers can accommodate small runs. If you want a proprietary mould, a custom dropper, or a glass bottle from an overseas supplier, the packaging vendor's own MOQ (often 3,000–10,000 units) becomes the real constraint — not the filling facility. Geography also shifts the range. US and EU contract manufacturers running GMP-certified clean rooms typically set pilot-batch floors at 500 units. Some Asian manufacturers (particularly in South Korea and Taiwan, where PGA fermentation-derived raw materials originate) accept 200-unit runs but require air-freight logistics that offset the unit-cost advantage. Regulatory markets influence the floor as well. A finished product intended for EU sale requires a product safety report and an EU-responsible person before it can be sold — paperwork some smaller manufacturers will not shoulder for orders under 500 units. The most common mistake first-time founders make is negotiating MOQ before locking in packaging. Confirm your component supplier's minimum first, then approach the filling facility with that confirmed number — you'll avoid the costly situation where the manufacturer can do 300 units but the airless pump supplier requires 5,000. AJ Cosmo Labs lets you filter its manufacturer directory by MOQ so you only see suppliers whose floor matches your production plan. Post a brief inside the app and specify your target quantity upfront to get accurate quotes without back-and-forth.

The all-in cost to private label a polyglutamic acid moisturizer typically ranges from $4 to $14 per finished unit at quantities between 200 and 10,000 units. That wide band reflects genuine variation in inputs — here is how to understand where your project will land. Raw material grade is the biggest single driver. Pharmaceutical-grade PGA with a narrow molecular-weight distribution costs $80–$160 per kilogram wholesale; cosmetic-grade material runs $40–$80 per kilogram. At a typical finished formula inclusion rate of 1–3%, the per-unit ingredient cost difference is $0.10–$0.50 — meaningful at low volumes, less so as you scale. If you add supporting actives like niacinamide, ceramides, or peptides, budget an extra $0.50–$2.00 per unit depending on concentration. Filling and labour costs depend on batch size and equipment type. At 200–500 units, many facilities charge a setup or changeover fee of $500–$1,500 in addition to a per-unit filling rate. At 2,000+ units that setup fee amortises to a few cents per unit. Expect filling-only costs (excluding materials and packaging) of $1.50–$3.50 per unit at small volumes. Packaging is often the most underestimated cost. A 50 ml stock airless pump in white or black typically costs $0.80–$1.60 per unit at low MOQ. A frosted glass jar runs $1.20–$2.50. PCR (post-consumer recycled) plastic adds a 15–30% premium. Private label printing on a stock component (sleeve label or direct print) is usually $0.20–$0.60 per unit; custom-moulded packaging requires tooling fees of $3,000–$15,000 before any per-unit cost. Regulatory and testing costs are one-time but material for small brands. Accelerated stability testing runs $800–$2,500 depending on number of time points and lab. A dermatologist-assessed safety substantiation report for EU compliance is typically $1,200–$3,000. A 48-hour patch test or RIPT study with a panel of 50 subjects costs $1,500–$4,000. Spread across 500 units these add $5–$15 per unit; spread across 5,000 they become negligible. A realistic all-in budget for a 500-unit first run of a quality PGA moisturizer in a stock airless pump with private label artwork, basic stability data, and US-compliant labeling is $5,000–$9,000, or roughly $10–$18 per unit. Brands that view this cost as per-unit COGS rather than total project investment often undercapitalise and cut corners on stability testing — the most common and expensive mistake at this stage. For a fast cost estimate, open the AJ Cosmo Labs app, post your product brief with target volume and packaging preference, and compare quotes from multiple manufacturers in one place.

From initial brief to finished product arriving at your warehouse, a private label polyglutamic acid moisturizer takes 8–16 weeks for most low-MOQ projects. The exact timeline depends on whether you start with a stock formula base or a fully custom development, and how quickly regulatory documentation is completed in parallel. Weeks 1–2 cover supplier selection and contracting. This means signing a non-disclosure agreement, reviewing the manufacturer's stock PGA formula options or custom development proposal, agreeing on specifications, and countersigning a manufacturing agreement or purchase order. Founders who skip the NDA step — eager to move fast — sometimes find their formula concept visible on a supplier's portfolio page six months later. Weeks 2–6 cover formula development and lab sampling. If your manufacturer has a validated PGA base, they will customise texture, scent, and actives load and ship you a first sample within 2–3 weeks. Two or three sample rounds are normal before brand approval. Each round adds 1–2 weeks if the manufacturer is offshore. Budget for courier costs ($40–$120 per shipment) to receive samples for evaluation. Weeks 4–10 cover stability and safety testing, which often runs in parallel with the later sample rounds. Accelerated stability (40 °C / 75% RH) takes a minimum of 12 weeks for full data, but most manufacturers release production to run once the 4- and 8-week data points pass without anomaly. Microbial challenge testing (preservative efficacy test) adds another 4 weeks and should run concurrently. Weeks 4–7, also in parallel, cover artwork and label finalisation. Your packaging designer needs the confirmed component dimensions, and the label must clear an INCI review for each market. EU brands need label copy reviewed against Regulation 1223/2009 claim language. Rushing artwork is the most common cause of late-stage delays: printers typically need print-ready files 2–3 weeks before filling is scheduled. Weeks 8–14 cover production filling, QC release, and dispatch. A 500-unit batch typically fills in one day; QC review and certificate of analysis generation adds 3–5 business days. International shipping from Asia adds 2–4 weeks by sea or 5–7 days by air. The most common delay is waiting on component lead times — particularly airless pump dispensers, which can have 6–10 week lead times from overseas component suppliers. Order components before formula development is complete, not after. Use the AJ Cosmo Labs app to post your brief, track sample rounds, and receive push notifications when your manufacturer hits each milestone — so nothing sits unactioned in an email inbox.

Commercial polyglutamic acid moisturizers typically include PGA at concentrations between 0.5% and 5% of the finished formula. The right level for your product depends on the molecular weight of the PGA you source, the other humectants in the formula, the intended skin type, and your cost targets. Low-molecular-weight PGA (under 100 kDa) penetrates deeper into the upper layers of the stratum corneum and works more like hyaluronic acid — delivering humectancy within the skin. Concentrations of 0.5–2% are effective and keep raw material costs manageable. High-molecular-weight PGA (500 kDa and above) is a superior surface film-former: it sits on top of the skin, locks in moisture, and creates the distinctive slightly tacky or silky skin-feel that consumers associate with K-beauty serums. Most surface-focused formulas use 1–3% of high-MW PGA. Combining both grades — a low-MW fraction for deeper humectancy and a high-MW fraction for surface film — is increasingly common in premium formulas and requires a cosmetic chemist with specific PGA experience to balance viscosity and skin feel correctly. At concentrations above 3–4%, high-MW PGA can significantly increase formula viscosity, which changes the texture profile and may require rheology modifier adjustments. It can also interact with cationic polymers (like polyquaterniums used in some hair-care-crossover skin products) and high-charge-density preservatives. From a regulatory and claims perspective, no minimum efficacy threshold is legally defined for PGA in either the US or EU cosmetics frameworks, but independent clinical testing (corneometry for moisture retention, TEWL measurement) is increasingly expected by buyers if you make specific claims like 'increases skin hydration by X%'. Reputable third-party labs can design a small consumer or instrumental study around your finished formula. A cosmetic chemist you connect with through AJ Cosmo Labs can recommend the optimal PGA grade and concentration for your target consumer, price point, and regional market.

Polyglutamic acid is legal for use in cosmetic products sold in the United States. The FDA does not 'approve' cosmetic ingredients the way it approves drug ingredients; instead, cosmetic ingredients must be safe for their intended use under the FD&C Act. PGA has no restrictions, prohibitions, or limits under FDA cosmetics regulations, and it does not appear on any prohibited or restricted list. Under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), which significantly updated US cosmetics law, brands and manufacturers now have new obligations regardless of the ingredients used. Facilities must register with the FDA (deadline passed December 29, 2023 for existing facilities). Products must be listed in the FDA's Voluntary Cosmetic Registration Program system (now mandatory for most commercial products). Safety substantiation must be on file — meaning the responsible party must have data or reasoned assessment supporting the product's safety before it is marketed. Serious adverse event reports must be submitted to the FDA within 15 days. These MoCRA obligations fall on the 'responsible party,' which is typically the brand owner, not the contract manufacturer — though your manufacturer should be registered as a facility and should have GMP documentation that supports your safety substantiation file. In the European Union, PGA is not listed as a prohibited or restricted substance under Annex II or Annex III of EU Cosmetics Regulation 1223/2009. A product containing PGA can be placed on the EU market provided the brand has a Product Safety Report (PSR) signed by a qualified safety assessor, an EU-responsible person on record, a Product Information File (PIF), and labeling compliant with EU INCI naming conventions. In South Korea, where much of the commercial PGA supply originates from fermentation, the ingredient is regulated under the Ministry of Food and Drug Safety (MFDS) Cosmetics Act and is freely used in cosmetics without restriction. For brands targeting multiple markets, the key action item is confirming your contract manufacturer's compliance posture — specifically whether they have GMP documentation, registered facilities, and can support your safety substantiation process. The AJ Cosmo Labs app lists each manufacturer's certifications so you can filter for FDA-registered, ISO 22716-certified, or EU-compliant facilities from the outset.

Finding a genuinely vetted low-MOQ manufacturer for a polyglutamic acid moisturizer requires more than a Google search and a round of cold emails. The vetting process has several distinct layers, and skipping any one of them is the root cause of most failed product launches. Start with manufacturing capability verification. A contract manufacturer must be able to demonstrate hands-on experience with PGA as an active — not just as a mentioned ingredient in their ingredient library. Ask specifically: 'Do you have an existing PGA moisturizer base with stability data on file?' A yes with documentation is a strong signal. A vague 'yes, we can source that' is not. Second, verify regulatory compliance documentation before any money changes hands. At minimum, ask for their current ISO 22716 GMP certificate or equivalent, their FDA facility registration number (for US products), and an example Certificate of Analysis from a recent batch. These documents are standard requests that any serious manufacturer will fulfil without hesitation. If a low-MOQ supplier hesitates, that is a disqualifying signal. Third, evaluate their sample process. Reputable manufacturers include 2–3 rounds of lab samples in their development agreement. Manufacturers who charge steep per-sample fees above normal courier costs, or who offer only one sample round, are either inexperienced with custom development or trying to reduce scope to hit artificially low quoted prices. Fourth, check financial protection mechanisms. When working with a new manufacturer, milestone-based payment — typically 30–40% deposit, 30% on formula approval, and 30–40% on QC release — is standard. Manufacturers who demand full payment upfront for first-time clients are a red flag. Fifth, assess communication responsiveness during the sourcing phase itself. If a manufacturer takes more than 48 hours to respond to your initial brief during the sales process, that response time will likely be worse during production when your money is already committed. Regional caveats: US-based manufacturers are generally more accessible for iterative collaboration, easier to audit in person, and more aligned with MoCRA compliance needs, but their unit costs are higher. South Korean manufacturers often have the deepest PGA formulation expertise and competitive pricing, but time-zone and language gaps require a more structured brief and longer sample lead times. EU manufacturers are well-aligned for European market launch but may have higher MOQs than Asian counterparts. The AJ Cosmo Labs app shortens this entire process by maintaining a curated directory of admin-reviewed cosmetic manufacturers, each with listed MOQ, certification status, and category specialisation. You post a brief describing your PGA moisturizer concept — target format, MOQ, markets, timeline — and receive structured quotes from manufacturers who have already passed the platform's baseline vetting. Download AJ Cosmo Labs from the App Store to get started.

Yes, polyglutamic acid and hyaluronic acid are fully compatible and are increasingly co-formulated in premium moisturizers because they act on different layers of the skin and complement each other's mechanisms. Hyaluronic acid (HA), particularly low-molecular-weight fractions, penetrates the stratum corneum and delivers humectancy within the upper skin layers. High-molecular-weight HA sits closer to the surface. PGA, especially high-molecular-weight grades, forms a film on the skin's outermost surface that dramatically reduces transepidermal water loss (TEWL), effectively sealing in the hydration that HA delivers deeper down. The combination produces synergistic, layered moisturisation that neither ingredient achieves as efficiently alone — which is why 'PGA + HA' has become a common claim pairing on product front panels. From a formulation standpoint, both ingredients are anionic (negatively charged) polymers, so they do not antagonise each other ionically. The cosmetic chemist's main task is managing overall formula viscosity: two high-MW film-forming polymers together can produce a texture that is too heavy, tacky, or stringy for leave-on use. The solution is usually to balance their molecular-weight grades — pairing low-MW HA with high-MW PGA, or vice versa — and to adjust the rheology with a compatible thickener or by reducing the concentration of each component slightly. Common inclusion rates in dual-humectant formulas: sodium hyaluronate at 0.5–2%, PGA at 0.5–2%. Total humectant load above 4% combined often requires texture adjustment. The formula pH should stay in the 5.0–6.5 range to maintain both polymers' stability and skin compatibility. Stability testing remains essential even though the two ingredients are compatible in principle. Batch-to-batch variation in raw material molecular weight can shift viscosity and skin feel, so your manufacturer should test the combined formula — not just each ingredient individually — across accelerated stability conditions. For founders building a hero moisturizer around a 'PGA + HA' positioning, a cosmetic chemist with direct experience in both actives is strongly preferable to a generalist formulator. The AJ Cosmo Labs app lets you specify this requirement in your brief and match with chemists who have relevant formulation experience.